NARB Panel Finds Philosophy's Study Reliable For Time In A Bottle Claims
This article was originally published in The Rose Sheet
The National Advertising Review Board's ruling on Coty/Philosophy's claims promoting the Time in a Bottle serum is considerably more favorable than the National Advertising Division's initial decision last year. Notably, the appellate body finds the advertiser's key clinical study reliable to support modified versions of statements NAD said should be discontinued, including a "two years younger" anti-aging claim.
You may also be interested in...
NAD recommends discontinuation of numerous claims, many on product packaging, for the Coty brand’s Time in a Bottle Age-Defying Serum, citing flaws in the advertiser’s six-month, blinded clinical study. Philosophy will appeal to the National Advertising Review Board, arguing that “left uncorrected, the NAD’s decision would … disincentivize manufacturers from conducting similar comprehensive studies.”
Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.
Federal preemption of state and local requirements that differ from federal mandates came up repeatedly at the House Energy & Commerce Health Subcommittee’s 4 December cosmetics hearing. Meanwhile, both NGO and industry stakeholders generally support FDA review of cosmetic ingredients, but the details of such a framework likely will be contentious as work progresses.